The majority of patients with community-acquired pneumonia are at low
risk for short-term mortality or serious morbidity and are increasingl
y managed in the outpatient setting. Efforts to improve the quality of
care for these patients will need to measure patient outcomes such as
disease-specific symptom resolution. The aims of this study were to (
1) develop a self-administered daily version of a symptom questionnair
e for patients with pneumonia, (2) measure the reliability of this ins
trument, and (3) provide estimates for recovery rates based on symptom
resolution in a cohort of low-risk patients with community-acquired p
neumonia. This study was conducted as part of a prospective study of a
new emergency department protocol for pneumonia at the Massachusetts
General Hospital. Eligible study subjects included all adult patients
with pneumonia presenting to the emergency department with a predicted
low risk of short-term mortality. The main outcome measures were base
d on a new five item symptom questionnaire which rates the severity of
cough, fatigue, dyspnea, myalgia, and fever. The questionnaires were
self-administered on days 0-7, 14, 21 and 28 from the time of diagnosi
s of pneumonia. The symptom questions were also administered during pa
tient interviews on days 0, 7, 14 and 28 in order to assess the questi
onnaire's reliability. Of the 166 eligible patients, 134 (81%) consent
ed to participate in this study. The mean intra-class reliability coef
ficient of the symptom questionnaire was 0.75. The median times to res
olution of individual symptoms ranged from 3 days for fever to 14 days
for cough and fatigue. Thirty-five percent of patients had at least o
ne symptom still present at the end of the 28-day study period.We foun
d that a daily self-report questionnaire is a reliable measure of symp
tom resolution for patients with pneumonia. Full resolution of symptom
s takes more than 28 days for a significant proportion of patients wit
h pneumonia.